LMR Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-141
| Closed | -$3.97K | – | 737 |
|
|
2024
Q2 | $3.97K | Hold |
141
| – | – | ﹤0.01% | 650 |
|
|
2024
Q1 | $42.3K | Buy |
+141
| New | +$42.3K | ﹤0.01% | 579 |
|
|
2021
Q3 | – | Sell |
-229
| Closed | -$53K | – | 1068 |
|
|
2021
Q2 | $53K | Buy |
+229
| New | +$53K | ﹤0.01% | 981 |
|
|
2021
Q1 | – | Sell |
-105
| Closed | -$40K | – | 999 |
|
|
2020
Q4 | $40K | Sell |
105
-45
| -30% | -$17.1K | ﹤0.01% | 463 |
|
|
2020
Q3 | $46K | Hold |
150
| – | – | ﹤0.01% | 391 |
|
|
2020
Q2 | $57K | Buy |
+150
| New | +$57K | ﹤0.01% | 526 |
|
|
2014
Q3 | – | Sell |
-197
| Closed | -$166K | – | 390 |
|
|
2014
Q2 | $166K | Buy |
+197
| New | +$166K | 0.01% | 415 |
|